A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 [EB-1010] in Patients With Major Depressive Disorder

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 [EB-1010] in Patients With Major Depressive Disorder

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2012

At a glance

  • Drugs Amitifadine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors DOV Pharmaceutical
  • Most Recent Events

    • 01 Jan 2012 Results published in the Journal of Psychiatric Research.
    • 07 Sep 2011 Results presented at the 24th Annual Congress of the European College of Neuropsychopharmacology.
    • 18 May 2011 Results presented at the 164th Annual Meeting of the American Psychiatric Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top